E-News - September 2026
Alliance News Update
Sharing News from the Alliance: September Media Mentions
The media relations efforts from Alliance staff and researchers are designed to alert the public about the vital work happening across our network. When we share stories about clinical trial results, scientific milestones, or investigator achievements, we are showcasing the real-world progress you help make possible.
See where the Alliance was mentioned September 2026 in the links below.
Alliance trial results
ASTRO 2026: Fractionated radiosurgery reduces recurrence after surgery for brain metastases
Delivering focused radiation therapy over three to five sessions after surgery for a large brain metastasis reduced the risk of cancer recurrence at the surgical site compared with delivering the radiation in a single session, according to the results of the Alliance A071801 presented at the plenary session of the 2026 American Society for Radiation Oncology Annual Meeting. The results were covered by the ASCO Post, Medscape, Healio, Medical Daily, Cure, News Medical, Cancer Network, Medical Xpress, Clinical Research News, Mayo Clinic News, Patient Daily, Mirage News, Head Topics, Bright Surf, Hoodline, Newswise, Find Articles, Australia’s Inkl, China’s Sohu.com, and Korea’s Global Business News. Read the Alliance news release.
Standard pediatric ALL therapy may also be safe in people over age 40
The CALGB/Alliance10403 protocol used in adolescents and young adults with acute lymphoblastic leukemia (ALL) may be equally safe and effective in adults aged 40 or more years, according to new study results, reported Medscape, Hematology Advisor and Rare Disease Advisor.
Alliance RadiCaL trial results show radium-223 does not delay serious bone issues in kidney cancer
Results from the Alliance for Clinical Trials in Oncology’s Phase II RadiCaL trial (Alliance A031801), the first randomized study of a radiopharmaceutical in kidney cancer, found that adding radium-223 to cabozantinib did not improve the length of time patients went without a symptomatic skeletal event in patients with metastatic kidney cancer and bone metastases. The findings are published in the Journal of Clinical Oncology, reported Health Medicine Network, eCancer and Mirage News. Read the Alliance news story.
AFT-38 PATINA trial supports FDA approval
The U.S. Food and Drug Administration (FDA) has approved palbociclib in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for patients with hormone receptor-positive, HER2-positive, locally advanced or metastatic breast cancer, reported dozens of news outlets, including the American Society for Clinical Laboratory Science News Bytes, OncoDaily and Spain’s Salud a Diario, La Razon, PM Pharma, and El Debate. The approval is based on results from the AFT-38/PATINA trial, published in the New England Journal of Medicine. Read the Alliance news release.
Alliance trial awareness
Prostate Cancer Awareness Month: How Alliance trials aid early detection, treatments
During Prostate Cancer Awareness Month in September, and the Alliance for Clinical Trials in Oncology highlighted how clinical research advances better treatments and improves early detection to help prevent and ultimately cure prostate cancer, reported Korea’s Mediadale and EurekAlert. Read the Alliance news story.
Alliance ERASur trial expands outside the U.S., hits accrual milestone
The ERASur trial (Alliance A022101) is exploring total ablative therapy for limited metastatic colorectal cancer and recently hit its one-third patient accrual milestone. The trial is now also available at sites in several countries outside the United States, reported OncoDaily. Read the Alliance news story.
Blood Cancer Awareness Month: How Alliance trials are helping improve treatments, early detection and survivorship
During Blood Cancer Awareness Month in September, the Alliance highlighted the importance of clinical research in advancing the treatment and prevention of leukemia, lymphoma, myeloma and other cancers affecting the blood-forming and lymphatic systems, reported EurekAlert. Read the Alliance news article.
